This meeting will allow opportunity for discussion of recent results relating the activities of all transglutaminase enzymes with cardiovascular diseases, neurological diseases, cancer and signalling disorders, celiac disease and inflammation, fibrosis and remodelling disorders. Additionally, this meeting will focus on emerging diseases associated with this class of enzymes, and new methods for their investigation.
The conference will consist of nine sessions, on the topics listed below. The conference chair is currently developing their preliminary program, which will include the names of the invited speakers and discussion leaders for each of these sessions. The preliminary program will be available by October 15, 2019. Please check back for updates.
- Keynote Session: Clinical Relevance of Tissue Transglutaminase Druggability
- Emerging Research Tools
- Emerging Diseases
- Cardiovascular Diseases
- Neurological Diseases
- Cancer and Signalling Disorders
- Celiac Disease and Inflammation
- Fibrosis and Remodelling
- Keynote Session: Activation and Inactivation of Tissue Transglutaminase